Redirect Notice
 The previous page is sending you to https://www.prnewswire.com/news-releases/fusion-pharmaceuticals-to-be-acquired-by-astrazeneca-accelerating-development-of-next-generation-radioconjugates-to-treat-cancer-302092258.html.

 If you do not want to visit that page, you can return to the previous page.